Last 12 months
Inside the activity.
0 purchase rows · 279 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 31 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 111 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 106 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,600 | $0.00 Strike: $88.95 | $0.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · derivative · entry 21 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 3,600 shares Expires 2025-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F9 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,439 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · derivative · entry 20 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,439 shares Expires 2023-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F9 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,388 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · derivative · entry 19 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,162 Underlying: Common Stock · 1,388 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F9 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionPerformance Stock Option 2014 (right to buy) · Derivative | 2,750 | $0.00 Strike: $96.45 | $0.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · derivative · entry 18 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,750 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionPerformance Stock Option 2014 (right to buy) · Derivative | 2,750 | $0.00 Strike: $96.45 | $0.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · derivative · entry 17 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750 Underlying: Common Stock · 2,750 shares Expires 2024-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionPerformance Stock Option 2013 (right to buy) · Derivative | 1,667 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · derivative · entry 16 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,667 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 600 | $135.00 | $81,000.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 14 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F7 · price: Sale prices ranged from $134.94 to $135.10 Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 400 | $133.83 | $53,532.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 13 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F6 · price: Sale prices ranged from $133.78 to $134.11. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 1,591 | $132.98 | $211,571.18 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 12 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F5 · price: Sale prices ranged from $132.75 to $133.71. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 12,405 | $132.18 | $1,639,692.90 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 11 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,591 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F4 · price: Sale prices ranged from $131.75 to $132.71. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 16,500 | $131.20 | $2,164,800.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 10 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,996 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F3 · price: Sale prices ranged from $130.74 to $131.73. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
SaleCommon Stock | 5,249 | $130.42 | $684,574.58 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 9 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,496 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. F2 · price: Sale prices ranged from $129.74 to $130.72. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 3,439 | $63.00 | $216,657.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 8 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 6,187 | $96.45 | $596,736.15 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 7 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 10,000 | $97.72 | $977,200.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 6 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 2,750 | $96.45 | $265,237.50 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 5 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 2,750 | $96.45 | $265,237.50 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 4 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 3,600 | $88.95 | $320,220.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 3 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 1,667 | $63.00 | $105,021.00 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 2 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 22:02 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 1,388 | $42.22 | $58,601.36 |
DisclosureSEC source: 0001325812-18-000004 · edgardoc.xml · nonDerivative · entry 1 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Read SEC document |
| December 30, 2017 Filed Jan 3, 2018 22:26 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001325812-18-000002 · primary_doc.xml · derivative · entry 4 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ALNY common stock. F3 · derivative.exercise_date: The restricted stock units vest in full on December 30, 2017. F3 · derivative.expiration_date: The restricted stock units vest in full on December 30, 2017. Read SEC document |
| December 30, 2017 Filed Jan 3, 2018 22:26 UTC |
Mason MichaelVP, Finance and Treasurer
|
Tax withholdingCommon Stock | 3,538 | $127.05 | $449,502.90 |
DisclosureSEC source: 0001325812-18-000002 · primary_doc.xml · nonDerivative · entry 2 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,964 Read SEC document |
| December 30, 2017 Filed Jan 3, 2018 22:26 UTC |
Mason MichaelVP, Finance and Treasurer
|
Exercise / conversionCommon Stock | 8,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001325812-18-000002 · primary_doc.xml · nonDerivative · entry 1 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 22:13 UTC |
KEATING LAURIESVP, GC & Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $77.40 | $0.00 |
DisclosureSEC source: 0001325812-18-000001 · primary_doc.xml · derivative · entry 3 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,000 Underlying: Common Stock · 3,000 shares Expires 2024-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 22:13 UTC |
KEATING LAURIESVP, GC & Secretary
|
Exercise / conversionCommon Stock | 3,000 | $77.40 | $232,200.00 |
DisclosureSEC source: 0001325812-18-000001 · primary_doc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
Mason MichaelVP, Finance and Treasurer
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 1,388 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000040 · edgardoc.xml · derivative · entry 1 Mason Michael · CIK 0001514291 · VP, Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388 Underlying: Common Stock · 1,388 shares Expires 2026-12-20 F1 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
Greenstreet YvonneEVP, Chief Operating Officer
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000039 · edgardoc.xml · derivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F1 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
KEATING LAURIESVP, GC & Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,249 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000038 · primary_doc.xml · derivative · entry 7 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,751 Underlying: Common Stock · 6,249 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F7 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
KEATING LAURIESVP, GC & Secretary
|
GrantPerformance Based Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000038 · primary_doc.xml · derivative · entry 6 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F6 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
KEATING LAURIESVP, GC & Secretary
|
SaleCommon Stock | 300 | $122.53 | $36,759.99 |
DisclosureSEC source: 0001325812-17-000038 · primary_doc.xml · nonDerivative · entry 4 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F4 · price: Sale prices ranged from $122.51 to $122.58. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
KEATING LAURIESVP, GC & Secretary
|
SaleCommon Stock | 1,900 | $121.67 | $231,181.93 |
DisclosureSEC source: 0001325812-17-000038 · primary_doc.xml · nonDerivative · entry 3 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,800 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F3 · price: Sale prices ranged from $121.49 to $122.39. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
KEATING LAURIESVP, GC & Secretary
|
SaleCommon Stock | 4,049 | $120.88 | $489,456.48 |
DisclosureSEC source: 0001325812-17-000038 · primary_doc.xml · nonDerivative · entry 2 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F2 · price: Sale prices ranged from $120.45 to $121.40. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 22:00 UTC |
KEATING LAURIESVP, GC & Secretary
|
Exercise / conversionCommon Stock | 6,249 | $42.22 | $263,832.78 |
DisclosureSEC source: 0001325812-17-000038 · primary_doc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · SVP, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 21:45 UTC |
Vaishnaw AkshayEVP, R&D
|
GrantPerformance Based Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000037 · primary_doc.xml · derivative · entry 3 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F2 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 21:36 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
GrantPerformance Based Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000035 · primary_doc.xml · derivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F2 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 21:37 UTC |
Greene Barry EPresident
|
GrantPerformance Stock Option 2016 (right to buy) · Derivative | 6,250 | $0.00 Strike: $42.22 | $0.00 |
DisclosureSEC source: 0001325812-17-000036 · edgardoc.xml · derivative · entry 1 Greene Barry E · CIK 0001291963 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2026-12-20 F1 · kind: On December 20, 2016, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. One quarter of the shares subject to the option will vest upon the achievement of each of four specific clinical development, regulatory or commercial events, as approved by our compensation committee. Effective December 20, 2017, the compensation committee of the Company determined the first performance criterion had been met and the option vested as to one-quarter of the shares. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 21:45 UTC |
Vaishnaw AkshayEVP, R&D
|
GiftCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001325812-17-000037 · primary_doc.xml · nonDerivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · EVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,215 Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 21:36 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,587 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001325812-17-000035 · primary_doc.xml · derivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,413 Underlying: Common Stock · 1,587 shares Expires 2023-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 21:36 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,587 | $63.00 | $99,981.00 |
DisclosureSEC source: 0001325812-17-000035 · primary_doc.xml · nonDerivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $77.40 | $0.00 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · derivative · entry 8 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 30,000 shares Expires 2024-09-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F8 · derivative.exercise_date: The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
SaleCommon Stock | 6,199 | $137.29 | $851,060.71 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · nonDerivative · entry 6 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F6 · price: Sale prices ranged from $137.04 to $137.73. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
SaleCommon Stock | 9,700 | $136.50 | $1,324,050.00 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · nonDerivative · entry 5 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,699 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F5 · price: Sale prices ranged from $136.00 to $136.95. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
SaleCommon Stock | 7,500 | $135.56 | $1,016,700.00 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · nonDerivative · entry 4 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,399 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F4 · price: Sale prices ranged from $134.99 to $135.93. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
SaleCommon Stock | 3,801 | $134.59 | $511,576.59 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · nonDerivative · entry 3 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,899 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F3 · price: Sale prices ranged from $133.95 to $134.92. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
SaleCommon Stock | 2,800 | $133.37 | $373,436.00 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · nonDerivative · entry 2 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,700 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. F2 · price: Sale prices ranged from $132.90 to $133.74. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:47 UTC |
KEATING LAURIESVP, GC and Secretary
|
Exercise / conversionCommon Stock | 30,000 | $77.40 | $2,322,000.00 |
DisclosureSEC source: 0001553878-17-000070 · primary_doc.xml · nonDerivative · entry 1 KEATING LAURIE · CIK 0001620743 · SVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017. Read SEC document |
| November 22, 2017 Filed Nov 24, 2017 23:55 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 73,415 | $0.00 Strike: $31.39 | $0.00 |
DisclosureSEC source: 0001553878-17-000069 · primary_doc.xml · derivative · entry 7 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,415 shares Expires 2017-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 13, 2017. The 73,415 options exercised and sold by the reporting person were due to expire on December 12, 2017. F7 · derivative.exercise_date: The stock option vested as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. F1 · derivative.expiration_date: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 13, 2017. The 73,415 options exercised and sold by the reporting person were due to expire on December 12, 2017. Read SEC document |
| November 22, 2017 Filed Nov 24, 2017 23:55 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 2,683 | $132.73 | $356,114.59 |
DisclosureSEC source: 0001553878-17-000069 · primary_doc.xml · nonDerivative · entry 5 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,710 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 13, 2017. The 73,415 options exercised and sold by the reporting person were due to expire on December 12, 2017. F5 · price: Sale prices ranged from $132.38 to $133.34. Read SEC document |
| November 22, 2017 Filed Nov 24, 2017 23:55 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 20,433 | $131.82 | $2,693,478.06 |
DisclosureSEC source: 0001553878-17-000069 · primary_doc.xml · nonDerivative · entry 4 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,393 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 13, 2017. The 73,415 options exercised and sold by the reporting person were due to expire on December 12, 2017. F4 · price: Sale prices ranged from $131.38 to $132.36. Read SEC document |
| November 22, 2017 Filed Nov 24, 2017 23:55 UTC |
MARAGANORE JOHNDirector · Chief Executive Officer
|
SaleCommon Stock | 25,036 | $130.88 | $3,276,711.68 |
DisclosureSEC source: 0001553878-17-000069 · primary_doc.xml · nonDerivative · entry 3 MARAGANORE JOHN · CIK 0001180432 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,826 F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 13, 2017. The 73,415 options exercised and sold by the reporting person were due to expire on December 12, 2017. F3 · price: Sale prices ranged from $130.38 to $131.37. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.